These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

656 related articles for article (PubMed ID: 35619896)

  • 21. Cuproptosis-related LncRNAs are potential prognostic and immune response markers for patients with HNSCC via the integration of bioinformatics analysis and experimental validation.
    Zhou L; Cheng Q; Hu Y; Tan H; Li X; Wu S; Zhou T; Zhou J
    Front Oncol; 2022; 12():1030802. PubMed ID: 36620545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A composite score based on immune-related gene prognostic index and m
    Yang Y; Cai Z; Huang K; Li M; Wang X; Lin Y; Chen S; Yang Z; Lin Z
    Front Genet; 2023; 14():1061569. PubMed ID: 36845378
    [No Abstract]   [Full Text] [Related]  

  • 23. A novel immune-related long non-coding RNA signature improves the prognosis prediction in the context of head and neck squamous cell carcinoma.
    Chen L; Cai Z; Lyu K; Cai Z; Lei W
    Bioengineered; 2021 Dec; 12(1):2311-2325. PubMed ID: 34167440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and validation of a novel signature based on cell-cell communication in head and neck squamous cell carcinoma by integrated analysis of single-cell transcriptome and bulk RNA-sequencing.
    Wang J; Sun HC; Cao C; Hu JD; Qian J; Jiang T; Jiang WB; Zhou S; Qiu XW; Wang HL
    Front Oncol; 2023; 13():1136729. PubMed ID: 37213285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma.
    Liu J; Lu J; Li W
    BMC Cancer; 2022 Mar; 22(1):352. PubMed ID: 35361159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Novel Inflammatory Response-Related Gene Signature Improves High-Risk Survival Prediction in Patients With Head and Neck Squamous Cell Carcinoma.
    Han Y; Ding Z; Chen B; Liu Y; Liu Y
    Front Genet; 2022; 13():767166. PubMed ID: 35480305
    [No Abstract]   [Full Text] [Related]  

  • 27. Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma.
    Bai Y; Lin H; Chen J; Wu Y; Yu S
    Front Mol Biosci; 2021; 8():645084. PubMed ID: 33968985
    [No Abstract]   [Full Text] [Related]  

  • 28. Characterization of tumor immune microenvironment and cancer therapy for head and neck squamous cell carcinoma through identification of a genomic instability-related lncRNA prognostic signature.
    Jing L; Du Y; Fu D
    Front Genet; 2022; 13():979575. PubMed ID: 36105083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A senescence-related lncRNA signature predicts prognosis and reflects immune landscape in HNSCC.
    Chen L; Lin J; Wen Y; Lan B; Xiong J; Fu Y; Chen Y; Chen CB
    Oral Oncol; 2024 Feb; 149():106659. PubMed ID: 38134702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel cuproptosis-related gene signature of prognosis and immune microenvironment in head and neck squamous cell carcinoma cancer.
    Jiang X; Ke J; Jia L; An X; Ma H; Li Z; Yuan W
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):203-218. PubMed ID: 36376617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma.
    Song D; Tian J; Han X; Li X
    Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
    Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
    Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
    [No Abstract]   [Full Text] [Related]  

  • 33.
    Chen L; Lin J; Lan B; Xiong J; Wen Y; Chen Y; Chen CB
    Comput Math Methods Med; 2022; 2022():5851755. PubMed ID: 36510584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pyroptosis-related gene expression signature predicts immune microenvironment and prognosis in head and neck squamous cell carcinoma.
    Zhou W; Feng M; Qi F; Qiao J; Fan L; Zhang L; Hu X; Huang C
    Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):953-963. PubMed ID: 38063904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic Value of a Ferroptosis-Related Gene Signature in Patients With Head and Neck Squamous Cell Carcinoma.
    He D; Liao S; Xiao L; Cai L; You M; He L; Huang W
    Front Cell Dev Biol; 2021; 9():739011. PubMed ID: 34790661
    [No Abstract]   [Full Text] [Related]  

  • 36. Investigation of an FGFR-Signaling-Related Prognostic Model and Immune Landscape in Head and Neck Squamous Cell Carcinoma.
    Chen Q; Chu L; Li X; Li H; Zhang Y; Cao Q; Zhuang Q
    Front Cell Dev Biol; 2021; 9():801715. PubMed ID: 35237609
    [No Abstract]   [Full Text] [Related]  

  • 37. The Prognostic Value of the DNA Repair Gene Signature in Head and Neck Squamous Cell Carcinoma.
    Ming R; Wang E; Wei J; Shen J; Zong S; Xiao H
    Front Oncol; 2021; 11():710694. PubMed ID: 34395285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and validation of a GRGPI model for predicting the prognostic and treatment outcomes in head and neck squamous cell carcinoma.
    Han F; Wang HZ; Chang MJ; Hu YT; Liang LZ; Li S; Liu F; He PF; Yang XT; Li F
    Front Oncol; 2022; 12():972215. PubMed ID: 36713509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and Validation of a Prognostic Signature Based on the Lysine Crotonylation Regulators in Head and Neck Squamous Cell Carcinoma.
    Jiang L; Yin X; Zhang H; Zhang X; Cao Z; Zhou M; Xu W
    Biomed Res Int; 2023; 2023():4444869. PubMed ID: 36814797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting the Immune Microenvironment and Prognosis with a NETosis-Related lncRNA Signature in Head and Neck Squamous Cell Carcinoma.
    He X; Xiao Y; Liu S; Deng R; Li Z; Zhu X
    Biomed Res Int; 2022; 2022():3191474. PubMed ID: 36147630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.